Rare Diseases, cell therapies and the value conundrum - food for thought
Considerations around ‘value’ assessment for gene and cell therapies in rare diseases was a theme addressed by several speakers, to close...
Considerations around ‘value’ assessment for gene and cell therapies in rare diseases was a theme addressed by several speakers, to close...
As a passionate advocate for gene and cell therapies, Fiona Thistlethwaite (Medical Oncology Consultant at The Christie Hospital &...
A thoughtful overview from Dr Richard Zajicek (Medicine and Process Delivery Leader, GSK) at the CAR-TCR Europe Summit2020, outlining the...
As a free user, you can follow Passle and like posts.
To repost this post to your own Passle blog, you will need to upgrade your account.
For plans and pricing, please contact our sales team at sales@passle.net